Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News

Synchron-FDA Prepares Large-Scale Brain Implant Trial Against Neuralink

Synchron CEO Tom Oxley poses at the Synchron offices in Brooklyn, New York City

In a groundbreaking development in the field of neurotechnology, Exclusive-Synchron, a competitor to Elon Musk's Neuralink, is gearing up to conduct a significant trial involving brain implants.

The trial, which has received approval from the Food and Drug Administration (FDA), marks a significant milestone in the company's efforts to advance brain-computer interface technology.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.